-transparent.png){kind=logo}
Multicellular tumor spheroids are largely exploited in cancer research since they are more predictive than bi-dimensional cell cultures. Nanomedicine would benefit from the integration of this three-dimensional in vitro model in screening protocols. In this brief work, we discuss some of the issues that cancer nanomedicine will need to consider in the switch from bi-dimensional to three-dimensional multicellular tumor spheroid models.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Martina Rossi, and
Paolo Blasi
January 1990,
Anticancer research,
Martina Rossi, and
Paolo Blasi
July 1988,
Cancer research,
Martina Rossi, and
Paolo Blasi
February 1983,
Cancer research,
Martina Rossi, and
Paolo Blasi
January 1989,
Anticancer research,
Martina Rossi, and
Paolo Blasi
August 2023,
Journal of nanobiotechnology,
Martina Rossi, and
Paolo Blasi
April 1981,
Journal of clinical ultrasound : JCU,
Martina Rossi, and
Paolo Blasi
May 2018,
Proteomics. Clinical applications,
Martina Rossi, and
Paolo Blasi
October 2011,
Physical review letters,
Martina Rossi, and
Paolo Blasi
October 2011,
Journal of biomolecular screening,
Martina Rossi, and
Paolo Blasi
September 1998,
Cancer letters,
